In a study with Chinese RA patients, the serum levels of TNF-α, IL-17, IL-6, and IFN-γ significantly decreased after the treatment with tofacitinib, parallel to an increase of IL-35, with subsequent T-reg lymphocyte response [85]. Here, IL6 is linked to rheumatoid arthritis.